Literature DB >> 33817428

Sympathetic context of the disease - a new era in glaucoma management.

Potop Vasile1,2, Coviltir Valeria1,2, Schmitzer Speranţa1,2, Ioana Ionescu Cătălina3, Gabriela Burcel Miruna3, Corbu Maria2, Margareta Cornelia Dăscălescu Dana1,3.   

Abstract

Primary open angle glaucoma (POAG) is a multifactorial optic neuropathy, which progresses in a chronic manner. Several etiological factors are involved, including genetic factors, race, age, IOP or vascular, systemic factors. IOP has an established role in the initiation and evolution of glaucoma, but its interactions with additional risk factors are complex. We propose the notion of the Glaucoma Etiological Area (GEA), as a representation of all the elements acting in collaboration in the physiopathology of each glaucoma case. When combined in different proportions, these elements may trigger the typical glaucomatous optic neuropathy (GON). We know that the statistical values of IOP are valid for normal eyes, but the glaucoma eye is not a normal eye. The notion of GEA can open a new perspective to interpret IOP values and to assess the true value of IOP control as a treatment for glaucoma. Applying the GEA theory allows us to tune the role of IOP. Additional factors, such as ocular properties (RGCL status, CCT, IOP fluctuation curve), ocular comorbidities (PEX, PDS), systemic comorbidities (arterial hypertension, vasospastic diseases such as migraines or Reynaud's syndrome) or patient's attitude towards glaucoma management (treatment compliance, access to follow-up and treatment) may greatly influence the evolution of GON and should be viewed holistically when developing a management plan for each patient. Applying the notion of GEA in clinical practice allows a more realistic approach of the pathophysiology of the disease and for a glaucoma treatment that is tailored to each patient. Abbreviations: AG = advanced glaucoma, BP = blood pressure, CCT = central corneal thickness, CIGTS = Collaborative Initial Glaucoma Treatment Study, CNTGS = Collaborative Normal-Tension Glaucoma Study, EMGT = Early Manifest Glaucoma Trial, GEA = glaucoma etiological area, GON = glaucomatous optic neuropathy, IOP = intraocular pressure, NTG = Normal Tension Glaucoma, OHTS = Ocular Hypertension Study, PDS = Pigmentary dispersion syndrome, PEX = Pseudoexfoliation syndrome, POAG - primary open-angle glaucoma, RGCL = retinal ganglion cell layer, VFL = visual field loss. ©Romanian Society of Ophthalmology.

Entities:  

Keywords:  IOP; contextual IOP; etiology; glaucoma

Year:  2021        PMID: 33817428      PMCID: PMC7995509          DOI: 10.22336/rjo.2021.4

Source DB:  PubMed          Journal:  Rom J Ophthalmol        ISSN: 2457-4325


  45 in total

1.  Abnormal flow-mediated vasodilation in normal-tension glaucoma using a noninvasive determination for peripheral endothelial dysfunction.

Authors:  Wei-Wen Su; Shih-Tsung Cheng; Tsu-Shiu Hsu; Wan-Jing Ho
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

Review 2.  Relationship between intraocular pressure and glaucoma onset and progression.

Authors:  Stefano Miglior; Francesca Bertuzzi
Journal:  Curr Opin Pharmacol       Date:  2012-10-31       Impact factor: 5.547

3.  Intraocular pressure decrease after phacoemulsification in patients with pseudoexfoliation syndrome.

Authors:  A Merkur; K F Damji; G Mintsioulis; W G Hodge
Journal:  J Cataract Refract Surg       Date:  2001-04       Impact factor: 3.351

4.  A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.

Authors:  Theodore Krupin; Jeffrey M Liebmann; David S Greenfield; Robert Ritch; Stuart Gardiner
Journal:  Am J Ophthalmol       Date:  2011-01-22       Impact factor: 5.258

5.  Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders.

Authors:  S S Hayreh; M B Zimmerman; P Podhajsky; W L Alward
Journal:  Am J Ophthalmol       Date:  1994-05-15       Impact factor: 5.258

6.  Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma.

Authors:  Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill; Luciana M Alencar; Pamela A Sample; Cristiana Vasile; Christopher Bowd
Journal:  Ophthalmology       Date:  2007-10-15       Impact factor: 12.079

7.  European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options.

Authors: 
Journal:  Br J Ophthalmol       Date:  2017-06       Impact factor: 4.638

Review 8.  The importance of corneal assessment in a glaucoma suspect - a review.

Authors:  Vasile Potop; Cătălina Corbu; Valeria Coviltir; Speranţa Schmitzer; Mihaela Constantin; Miruna Burcel; Cătălina Ionescu; Dana Dăscălescu
Journal:  Rom J Ophthalmol       Date:  2019 Oct-Dec

Review 9.  Ocular perfusion pressure and ocular blood flow in glaucoma.

Authors:  A Popa Cherecheanu; G Garhofer; D Schmidl; R Werkmeister; L Schmetterer
Journal:  Curr Opin Pharmacol       Date:  2012-09-23       Impact factor: 5.547

Review 10.  Ganglion Cell Complex Analysis in Glaucoma Patients: What Can It Tell Us?

Authors:  Gianluca Scuderi; Serena Fragiotta; Luca Scuderi; Clemente Maria Iodice; Andrea Perdicchi
Journal:  Eye Brain       Date:  2020-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.